anmelden
OMX Copenhagen PI
1.348,92
PKT
+4,30
PKT
+0,32
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Copenhagen PI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 09.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 09.08.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 08.08.19 | A.P. Moeller - Maersk A-S (B) neutral | Morgan Stanley | |
| 06.08.19 | Novo Nordisk Equal-Weight | Morgan Stanley | |
| 05.08.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 31.07.19 | Novo Nordisk buy | UBS AG | |
| 08.07.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 08.07.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 08.07.19 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 04.07.19 | Novo Nordisk Conviction Buy | Goldman Sachs Group Inc. | |
| 28.06.19 | A.P. Moeller - Maersk A-S (B) Hold | Deutsche Bank AG | |
| 20.06.19 | Novo Nordisk Hold | Deutsche Bank AG | |
| 18.06.19 | Novo Nordisk buy | UBS AG | |
| 17.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.06.19 | Novo Nordisk buy | Deutsche Bank AG | |
| 14.06.19 | A.P. Moeller - Maersk A-S (B) Hold | Deutsche Bank AG | |
| 13.06.19 | A.P. Moeller - Maersk A-S (B) buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 12.06.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 11.06.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 11.06.19 | Novo Nordisk buy | UBS AG | |
| 11.06.19 | Novo Nordisk Equal weight | Barclays Capital | |
| 11.06.19 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 05.06.19 | Novo Nordisk Outperform | Bernstein Research | |
| 30.05.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 29.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 28.05.19 | Novo Nordisk Reduce | HSBC | |
| 28.05.19 | A.P. Moeller - Maersk A-S (B) Outperform | Credit Suisse Group | |
| 28.05.19 | A.P. Moeller - Maersk A-S (B) verkaufen | Barclays Capital | |
| 28.05.19 | Novo Nordisk Reduce | HSBC | |
| 24.05.19 | A.P. Moeller - Maersk A-S (B) buy | Goldman Sachs Group Inc. | |
| 17.05.19 | A.P. Moeller - Maersk A-S (B) kaufen | Credit Suisse Group | |
| 17.05.19 | Novo Nordisk Underweight | Barclays Capital | |
| 07.05.19 | Novo Nordisk buy | UBS AG | |
| 07.05.19 | Novo Nordisk Neutral | Oddo BHF | |
| 07.05.19 | Novo Nordisk Reduce | HSBC | |
| 06.05.19 | Novo Nordisk Underweight | Barclays Capital | |
| 06.05.19 | Novo Nordisk Outperform | Credit Suisse Group | |
| 06.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 03.05.19 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
| 03.05.19 | Novo Nordisk overweight | JP Morgan Chase & Co. |
